Zyneyro ApS: Financial statements 2023
CVR: 42057428
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Zyneyro ApS (CVR 42057428) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,029,558 and a net result of DKK -34,534 compared with DKK -28,481 the year before. Equity in the 2023 report amounted to DKK -52,116. The company had 4 employees in the financial year.
- Gross Profit
- DKK 1,029,558
- Profit/Loss
- DKK -34,534
- Equity
- DKK -52,116
- Total Assets
- DKK 540,221
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1 mio. | -35 t. | -52 t. | 4 |
| 2022 | - | -27 t. | -28 t. | -18 t. | 0 |
| 2021 | - | -27 t. | -29 t. | 11 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Zyneyro ApS has published its annual report for 2022. Gross profit came to DKK -27,036, and the net result was DKK -28,481.
As of June 13, 2023, Revisionsfirmaet Tom Sønderup I/S has been appointed auditor of Zyneyro ApS.
As of June 13, 2023, City Administration II ApS has stepped down as auditor of Zyneyro ApS.
On January 3, 2023, the company changed its name from DolorestBio ApS to Zyneyro ApS.
About Zyneyro ApS
Zyneyro ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2021. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named DolorestBio ApS. The management consists of Steen Søren Klysner. The board consists of Jacob Ørndrup (chair), Andreas Toft Sørensen, Erik Vinther and Kenneth Lindegaard Madsen. The company's owners include Marigold Innovation ApS, IFO ApS and UGether ApS. The company has 10 employees (2026). In 2025, the company reported a gross profit of DKK -4,550,684 and a net result of DKK -7,466,446 compared with DKK 665,931 the year before. Equity in the 2025 report amounted to DKK 4,147,370.